Company Tagline
TiumBio is committed to developing innovative therapeutics for patients with rare or incurable diseases
Industry Category
Business Keywords
Company Description
TiumBio is a leading biopharmaceutical company dedicated to the discovery and development of innovative therapeutics for patients facing rare and incurable diseases. Located at 6F, Pangyo IT Center, 30 Changup-ro 40 beon-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do 13449, KR, TiumBio is committed to advancing scientific breakthroughs that enhance the hope and happiness of humanity.
TiumBio is focused on pioneering advancements in areas such as immuno-oncology and hemophilia. With a robust pipeline of clinical-stage assets, including TU2218, TU2670, and TU7710, the company is actively engaged in Phase 2 and Phase 1 clinical trials. These innovative therapies are designed to address critical unmet needs in women's health and various rare diseases. Additionally, TiumBio has a US subsidiary located at 22 Strathmore Rd, Natick, Massachusetts 01760.
TiumBio is dedicated to pushing the boundaries of biotechnology research and development. We invite the manager of TiumBio to create a customized and exclusive company showcase and product listing on our platform, highlighting the unique value and potential of TiumBio.
TiumBio는 희귀 및 불치병 환자를 위한 혁신적인 치료법 발견 및 개발에 전념하는 선도적인 바이오 제약 회사입니다. 대한민국 경기도 성남시 수정구 창업로 40번길 30, 판교IT센터 6층에 위치한 TiumBio는 인류의 희망과 행복을 증진시키는 과학적 혁신을 발전시키기 위해 노력하고 있습니다.
TiumBio는 면역 항암 및 혈우병과 같은 분야에서 획기적인 발전을 개척하는 데 중점을 두고 있습니다. TU2218, TU2670 및 TU7710을 포함한 강력한 임상 단계 자산 파이프라인을 통해 회사는 2상 및 1상 임상 시험에 적극적으로 참여하고 있습니다. 이러한 혁신적인 치료법은 여성 건강과 다양한 희귀 질환에서 충족되지 않은 중요한 요구를 해결하도록 설계되었습니다. 또한 TiumBio는 미국 매사추세츠주 Natick, Strathmore Rd 22에 미국 자회사를 두고 있습니다.
TiumBio는 생명 공학 연구 개발의 경계를 넓히는 데 전념하고 있습니다. TiumBio의 매니저님을 초대하여 당사 플랫폼에서 TiumBio의 고유한 가치와 잠재력을 강조하는 맞춤형 독점 회사 쇼케이스 및 제품 목록을 만들어 주시기 바랍니다.
Key Personnel / Employees
Compare Companies Side by Side
Compare TiumBio with 3 companies in Biotechnology-Research
| Comparison Field |
TiumBioMain Company |
HRA PharmaView Profile |
ImmuneedView Profile |
TJ BiopharmaView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2016 | |
|
Company Size
|
— | 51-200 | 11-50 | 201-500 |
|
City
|
Seongnam-si, Gyeonggi-do | Chatillon , Il | ||
|
Country
|
South Korea | |||
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Biopharmaceutical
Immuno-oncology
Rare Diseases
Clinical Trials
Therapeutics
Women's Health
Hemophilia
Women's health
Rare diseases
Discovery
Endometiosis
Small molecules
Development
|
7 Total
7 Unique
Unique Skills:
Contraception
Endocrinology
Healthcare
OTC
Reproductive health
RX-to-OTC switches
+1
|
21 Total
21 Unique
Unique Skills:
ADCC & CDC assays
Biologics
Complement Activation
Contract research organization
Cytokine Release Assay
Drug development
+15
|
6 Total
6 Unique
Unique Skills:
Autoimmune Diseases
Clinical Development
Commercial Partnership
GMP Manufacturing
Immunotherapy
Metabolic Disorders
|
4
Total Companies2014
Oldest Founded1
Countries47
Unique SkillsSimilar Companies
Other organizations in the same industry
Alphabioregen, Inc.
Biotechnology-ResearchMoving Research from 2D to 3D
Teleios R & D
Biotechnology-ResearchOptimized Holistic Health through Integrative Science
MYRIADE
Biotechnology-ResearchMeasuring Size & Concentration of Nanoparticles : in a single drop, in real time reproducible result...
Alternative Company Names
This company is also known as